OBjECTIVE: To observe the relationship between reduced pulmonary function and regulatory T cells (Tregs) and helper T cells (Th)1/Th2 drift in a rat model of adjuvant arthritis (AA), and to study the impact of Xinfeng capsule (XFC) on pulmonary function and investigate the mechanism of action.
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic panarthritis as the main clinical manifestation. It not only leads to joint deformities, but is also often accompanied by other visceral lesions. The lungs contain abundant connective tissue and are therefore most often affected, resulting in a decline of pulmonary function and lung tissue damage. Studies have found that lung diseases cause reduced pulmonary function in 60%-70% of RA patients. 1, 2 Early research found that rats with adjuvant arthritis have reduced pulmonary function, and pulmonary function decline is closely related to Th1 and Th2 cells and imbalanced expression of CD4 + CD25 + regulatory T cells (Tregs). 3, 4 Two types of CD4+ Th cells have different responses to cytokines. Interferon (IFN)-γ can induce the differentiation of Th1 cells, and inhibits Th2 cell proliferation, while interleukin-4 (IL-4) induces helper T cells (Th)2 cell differentiation. There is most likely inhomogeneity within Th1 and Th2 subsets from the point of performance and effect. This is known as "cloning drift" in which one subgroup of Th1/Th2 would enhance, while another subgroup of Th1/Th2 would abate function. The balance between Th1 and Th2 cells is broken in the pathogenesis of RA and the subsets drift in the wrong directions. This may lead to autoimmune response, directly causing the deterioration of RA. It is a trend in the treatment of many diseases to adjust the drift in right direction. [5] [6] [7] Studies have found that Traditional Chinese Medicine Xinfeng capsule (XFC), which consists of Huangqi (Radix Astragali Mongolici), Yiyiren (Semen Coicis), and Wugong (Scolopendra), can not only improve symptoms and signs of joints in patients with RA, but also obviously improve their pulmonary function. 8 XFC can improve RA symptoms such as joint swelling, joint pain and morning stiffness, and lower the indexes of joint pain and joint tenderness, reduce blood sedimentation, C-reactive protein, anti-cyclic citrullinated peptide (CCP), and rheumatoid factor. XFC can obviously improve the pulmonary function in patients with RA parameters such as forced vital capacity (VC), forced expiratory volume in 1 s (FEV1), forced respiration rate of 1 s (FEV1/FVC), forced vital capacity 25% of maximum expiratory flow (FEF25), forced vital capacity 50% of maximum expiratory flow (FEF50), forced vital capacity 75% of maximum expiratory flow (FEF75), largest tidal midexpiratory flow (MMF), and maximum expiratory flow (PEF). XFC can improve pulmonary symptoms and signs such as cough, sputum, chest tightness, wheezing, and short of breath. 9 In this paper, the effects of XFC on Th1/Th2 cells and Tregs in rats with adjuvant arthritis (AA) were observed based on previous studies. We aimed to study the impact of XFC on pulmonary function and investigate its mechanism of action.
MATERIALS AND METHODS

Ethical approval of the study protocol
The study protocol was approved by the Ethics Committee of First Affiliated Hospital, Anhui University of Chinese Medicine (Hefei, China).
Experimental animals
Forty male Sprague-Dawley (SD) rats (180-200) g were purchased from the Experimental Animal Center of Nanjing Medical University (Nanjing, China). All animals were housed in specific pathogen-free (SPF) conditions, and had free access to water and standard rat feed. Instruments and equipment PCR instrument was provided by Biometra Company Biometra GmbH (T-Gradient, Goettingen, Germany), and Applied Biosystems, Inc. (ABI7500, Foster City, CA, USA). Electrophoresis was from Amersham Biosciences (EPS-301, Uppsala, Sweden). Gel image analyzer was from Bio-RAD Corporation (Gel Doc XR, Hercules, CA, USA). Slicer was provided by LEICA Microsystems GmbH (KMI135, Wetzlar, Germany). Light microscopy was provided by LEICA Microsystems GmbH (DMLB, Wetzlar, Germany). Automatic microscope camera system was provided by OLYMPUS Corporation (CX31-32C02, Tokyo, Japan). Desktop high-speed refrigerated centrifuge was provided by Eppendorf AG (Centrifuge 5417R, Hamburg, Germany). Forty male SD rats were divided randomly into by random number table method: normal control (NC) group, model control (MC) group, Xinfeng capsule (XFC) group, and Tripterygium glycosides tablet (TPT) group, with 10 in each. Each group had no significant difference in baseline such as body weight, mice age, etc. (P>0.05). Except for the NC group, all others were intracutaneously injected with 0.1 mL FCA into the right hindlimb. 10 Administration began on the nineteenth day. The NC and MC groups were given 0.9% (physiological) saline (1 mL/100 g per day). The TPT and XFC groups were given TPT (10 mg/kg) and XFC (2.4 g/kg), respectively, for thirty days.
Drugs and reagents
Model replication and administration
Calculation of paw swelling (E) and arthritis index (AI)
Paw volume was measured every three days. Paw swelling (E) was calculated using the following formula:
Where Vn and Vt represent the volume of the paw before and after modeling, respectively. Systemic and joint disease caused by inflammation was recorded every three days. The AI was classified using a five-scale method: 0 point: no swelling; 1 point: swelling on the joint of the little toe; 2 points: swelling on the metatarsal phalange joint and foot; 3 points: swelling on the hindpaw below ankle swelling; 4 points: swelling on the hindpaw and including ankle swelling. The sum of points for each rat was calculated, and the highest possible score was 12 points.
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Evaluation of pulmonary function Several parameters of pulmonary function were evaluated. These included forced vital capacity (FVC) and average expiratory flow, which was calculated by dividing FVC by the value for forced expiratory flow in one second (FEV1) and multiplying by 100% . Further, 25% , 50%, and 75% of the vital capacity of the peak expiratory flow (FEF25, FEF50 and FEF75, respectively) were calculated. PEF was also assessed. These measurements were obtained using the pulmonary function test apparatus for small animals thirty days after administration. Rats were anesthetized with 10% chloral hydrate (0.35 mL/100 g, i.p.). Tracheotomy and endotracheal intubation were then carried out. The rats were then put into an airtight box. The ventilator tube was connected to the mechanical ventilation apparatus to collect pulmonary function. In this setup, external pressure caused deep inspiration. Computer software was used to measure each indicator automatically.
Detection of IFN-γ and IL-4 in serum using ELISA Detection was performed in accordance with the instructions of the enzyme-linked immunosorbent assay (ELISA) kit. The capture antibody (IL-4, IFN-γ) was diluted (1-10 μg/mL) in coating solution. One hundred µL diluted antibody was added to appropriate wells and incubated for 2 h at room temperature. Coating buffer were emptied and residual liquid removed. Plates were washed twice with 300 µL 0.05% tween-20, and then 300 µL blocking solution was added to each well and they were then incubated for 1 h at room temperature. Following this the plates were emptied and residual liquid removed. They were then washed twice with 300 µL wash solution. One hundred µL of diluted biotinylated detection antibody was added to each well and the plates were then incubated for 1 h at 37℃. Plates were then emptied and residual liquid removed. Each well was filled with wash solution, and plates were inverted to empty and tapped to remove residual liquid. This was repeated three times. One hundred µL diluted AKP conjugated streptavidin was then added to each well and incubated for 1 h at room temperature. Plates were then washed three times and given a final 5 min soak with wash solution. Each well was filled with wash solution, and repeated five times. Two hundred µL of substrate was then placed into each well. Color was developed for 30 min at room temperature. 0.05 mL 2 M of H2SO4 was added to each well, and plate was immediately with a plate reader at 405-410 nm.
Detection of CD4+ CD25+ FoxP3+ Treg in peripheral blood by flow cytometry
Fresh blood samples were collected from the rats, and whole blood samples were put into K3-EDTA containing tubes. Then, anti-mouse CD4-Per CP (20 µL) and anti-mouse CD25-FITC (10 µL) were added to each tube of blood (10 6 cells per tube), successively. Tubes were kept in dark for 15-20 min at room temperature (20℃-25℃ ). We then added 1 mL RBC lysate to the tube and incubated for 15-25 min in darkness. The tube contents were then washed with phosphate buffer (PBS) twice, centrifugation at 376 g, and the supernatant was discarded. 3 mL FoxP3 Buffer A were added at room temperature and incubated in darkness for 10-15 min. To each tube, we added 1 mL FoxP3 Buffer C, and mixed at room temperature in darkness for 20-30 min. FoxP3-PE (20 μL) was then added to each tube and kept in darkness for 15-20 min at room temperature. Each tube was washed with 3 mL PBS, low speed centrifugation at 211 × g, and heavy suspension cells with 500 μL PBS buffer. The expressions of CD4+ CD25+ Tregs and CD4+ CD25+FoxP3+ Tregs were measured by flow cytometry.
Detection of IFN-γ, IL-4, and FoxP3 mRNA in lung tissue by real-time quantitative Polymerase chain reaction (PCR)
Total lung RNA was extracted, and was dissolved by adding 30 μL RNase-free ddH2O. 500 ng of total RNA was reverse transcribed in 10 μL of reaction system (5× prime script buffer 2 μL, Prime Script RT Enzyme Mix Ⅰ 0.5 μL, Oligo dT Primer 0.5 μL, Random 6 mers 0.5 μL, diethypyrocarbonate (DEPC) wa-ter 6.5 μL). cDNA was then reverse transcribed (37℃ 15 min, 70℃ 60 min). PCR instrument amplification: the reaction system 20 μL (cDNA 2 μL, 2× Premix Ex Taq II 10 μL, 10 μmol/L PCR Forward/Reverse Primer 0.8 μL, 50× Roxanne Brown Reference Dye II 0.4 μL, dH2O 6 μL). PCR amplification program: 95°C denaturation for 30 s after the start cycle; 95℃ 5 s, 60℃ 34 s, 40 cycles. Results found: Ct values were recorded using the relative quantitative analysis, mRNA relative expression=2 ΔCt × 100%, where Δ Ct=Ct (target gene)-Ct (internal reference β-actin).
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Primer and probe sequences are shown in Table 1 .
Detection of IFN-γ, IL-4, and FoxP3 protein in lung tissue by western blot
Total protein in the lung tissue was extracted with Preparation of Modifed Radioimmunoprecipitation (RIPA) buffer. Protein assay kit was used for concentration measurement and protein concentration was diluted to 2 μg/μL. 16 μL of protein was mixed with 4 μL of sample buffer (5 × ) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10% separating gel, 5% concentrated gel). Electrophoresis was run at a constant voltage of 60 V until the top gel separated, and then it was run at a constant voltage of 100 V to separate the bottom gel. Protein was transferred to a nitrocellulose membrane with a constant current of 40 mA for 50 min. After blocking with 5% skim milk powder for 2 h, 1∶500 diluted IFN-γ, IL-4, and FoxP3 monoclonal antibody were added in, with bed shaking for 2 h. Membrane was washed in PBS three times, for 10 min each. Then, 1∶1000 diluted sheepHorseradish Peroxidase anti mouse IgG was added in with shaking for 1 h, and washed in PBS three times, for 10 min each time. Electrochemiluminescence (ECL) reagent was used for developing the stained band, and the result was scanned with a scanner. The stained bands were analyzed with BANDSCAN software to calculate the grey value, with grey levels of IFN-γ, IL-4, and FoxP3/beta-actin as the relative value of protein expression of IFN-γ, IL-4, and FoxP3 in lung tissue.
Statistical analyses
Continuous variables are expressed as mean ± standard deviation. All samples were tested to ascertain if they followed a normal distribution. The sample data have a normal distribution. Data comparison among groups was performed using ANOVA and and Homogeneity of Variance Tests. Comparison between groups was carried out using the independent samples t-test. SPSS Version 11.5 (SPSS Inc., Chicago, IL, USA) was used for data analyses. P<0.05 was considered significant.
RESULTS
Effects of XFC on pulmonary function in rats
Compared with the NC group, parameters of pulmonary function (FEV1, FEF50, FEF75, and PEF) were significantly reduced in the MC group. Values of FEV1, FEF75, and PEF in the XFC groups were higher than those in the MC group. Values of FEV1, FEF50, FEF75, and PEF in the XFC groups were higher than those in the MC group. Compared with the TPT group, FEF75 was increased in the XFC group (P<0.05 or P<0.01) ( Table 2 ).
Effects of XFC on paw swelling and AI in rats
At 6 h after inducing inflammation, the right rear toes of rats in modeling groups began to swell. On the third day after inducing inflammation, paw swelling reached a peak and then decreased gradually. Some of the forefeet toes began to show redness and swelling on day four and five. On day 12, the AI reached a peak, and then declined gradually. Thirty days after inducing inflammation, compared with the MC group, paw swelling and AI decreased in the XFC and TPT groups (P< 0.01), and no significant difference between the XFC group and TPT group was seen (P>0.05) ( Table 3) .
Influence of Xinfeng capsule on serum levels of IFN-γ, IL-4, and Th/Th2 cells in rats
Compared with those in the NC group, IFN-γ and Th1/Th2 serum levels in the MC group were in- Table 1 FoxP3 mRNA were lower in the NC group than those in the MC group. The expressions of IL-4 and FoxP3 mRNA were higher, and of IFN-γ mRNA was lower in the MC group than those in the XFC group. Compared with the XFC group, FoxP3 mRNA expression was decreased in the TPT group (P<0.05 or P<0.01). (Figure 4-6) .
Influence of Xinfeng capsule on levels of IFN-γ, IL-4, and FoxP3 protein in lung tissue in rats
The level of IFN-γ was higher, but the expression of IL-4 and FoxP3 protein were lower in the NC group than those in the MC group. Compared with the MC group, the level of IFN-γ was lower in the XFC group, while the expression IL-4 and FoxP3 were higher. Compared with the XFC group, the expressions of IL-10 and FoxP3 were lower in the TPT group (P<0.05 or P< 0.01) (Figure 7 ).
DISCUSSION
Mosmann et al tion and antibody production. They are also associated with humoral immunity. 6, 15 In the present study, the typical cytokines of Th1 and Th2, IFN-γ and IL-4 were observed. IFN-γ promotes cell inflammation and is an important regulatory factor on the body's inflammatory response and immune response. IFN-γ can also cause swelling in the joints in early RA, and stimulate synovial cells and cartilage cells to produce PGE2 and collagenase, which leads to local synovial inflammation and joint cartilage damage. It plays a central role in cytokine network of RA. 16, 17 IL-4 is an anti-inflammatory factor mainly secreted by Th2 cells. It can inhibit the T cells, eosinophils, NK cells, B cells and mast cells, which can produce proinflammatory cytokines and chemotactic factors. By inhibiting antigen-presenting cells, inducing T cells not to respond, and inhibiting inflammatory cells directly within the airway, IL-4 can control lung lesions in RA. Tregs can inhibit the expression of Th1 and Th2 cells, and the inhibition may be greater on Th1 cells than on the Th2 cells. Thus transformation of the immune response of polarization is regulated. [18] [19] [20] Indexes such as paw swelling degree, arthritis index, IFN-γ, and Th1/Th2 were increased in AA rats after FCA induced inflammation. At the same time, pulmonary function parameters, such as FEV1, FEF50, FEF75, PEF, and IL-4 were reduced. This indicates that immune complexes deposit in the joints in AA rats after inflammation, and further stimulate the release of inflammatory mediators. These processes involved in the local inflammatory response, prompt lesions in the lung tissue, and reduce pulmonary function. Among the pulmonary function parameters, FEF25, FEF50, and FEF75 reflect the function of small airways, and FEV1, MMF, and PEF reflect ventilation function. Therefore, small airway lesions and ventilation dysfunction are the main presentation of declining pulmonary function in AA rats. We found that CD4+ CD25+ Tregs in peripheral blood and expression of FoxP3 in lung tissue were decreased in AA rats. This suggests that reduced pulmonary function may be associated with regulating the expression of T cells and CD4+ CD25+ Tregs. As CD4+ CD25 + Tregs inhibit the expression of CD4 + CD25-T cells, a large number of inflammatory cytokines such as IFN-γ are released. Expression of Th1/Th2 increases, leading to Th1/Th2 drift to Th1 cells. Then, the expression of Th2 cells is inhibited, so the expression of inflammatory cytokines such as IL-4 and IL-10 is reduced, aggravating the lung tissue damage. This is consistent with findings from previous studies, which show that in AA rats, that there is alveolitis in lung tissues, and that the pulmonary coefficient is increased. 21, 22 Xinfeng capsule can reduce joint inflammation in AA rats obviously. After intervention with Xinfeng capsule, the right rear joint volume was lower in AA rats, and the degree of swelling in the joints and the arthritis index of body joint were decreased. In terms of improved pulmonary function parameters, Xinfeng capsule can significantly increase parameters of pulmonary function such as FEV1, FEF50, FEF75, and PEF. This indicates that Traditional Chinese Medicine Xinfeng capsule can not only improve the symptoms of the adjuvants inflammatory joints, but also improve pulmonary function in AA rats. We found that levels of inflammatory cytokines IFN-γ and Th1/Th2 cells in the serum decreased, and IL-4 levels were elevated. The expressions of CD4 + CD25 + Tregs and CD4 + CD25 + FoxP3+ Tregs also decreased in the peripheral blood after the treatment with Xinfeng capsule. Xinfeng capsule can obviously improve the levels of IL-4 and regulatory T cells, reduce the expression of IFN-γ, and balance the coordination of Th1/Th2 cells. This suggests that the effect of Xinfeng capsule on pulmonary function in AA rat may be related to regulating the immune balance and reducing the inflammatory response. Xinfeng capsule can raise the expression of CD4+ CD25+ Tregs and CD4+ CD25+ FoxP3+Tregs, further promoting antimicrobial inflammation cytokine secretion of IL-4, and inhibiting the expression of IFN-γ. Xinfeng capsule tends to balance the Th1/Th2 cell ratio, reduce the inflammatory response and immune complex target damage of lung tissues and organs, and improve the level of pulmonary symptoms and pulmonary function. 23 We found that IFN-γ mRNA and IFN-γ protein levels in lung tissue were decreased, using quantitative PCR and western blotting. FoxP3 (Treg surface markers), and IL-4 mRNA and protein in lung tissue were higher after the intervention of Xinfeng capsule in AA rats. This suggests that there is a balance between Th1/Th2 cells and the regulatory T cells. With increasing expression of regulatory T cells, normal immune tolerance is maintained, and the expression of Th1/Th2 cells keep balance. At the same time, because of this balance, inflammatory cell levels decrease, blood vessel osmotic pressure of lung tissue decreases, the inflammatory response to tissue organ stimulation is reduced, the ventilation function of lung tissue returns to normal, and the level of pulmonary function is increased. Xinfeng capsule consists of Huangqi (Radix Astragali Mongolici), Yiyiren (Semen Coicis), Wugong (Scolopendra), and Leigongteng (Radix et Rhizoma Tripterygii). It is believed in Traditional Chinese Medicine, that Huangqi (Radix Astragali Mongolici) benefits Qi for consolidation of superficies, induces diuresis for removing edema, invigorates spleen for removing dampness, and dredges channel blockades. Research in recent years shows that astragalosides, the total glycosides of Huangqi (Radix Astragali Mongolici), have good anti-inflammatory and immune regulatory effects. They can promote phagocytosis of macrophages. Astragalus polysaccharides can reduce edema and albumin leakage in acid lung injury, improve hypoxia, enhance oxidation resistance, reduce lung injury degree, ameliorate alveolitis and pulmonary fibrosis in lung tissue.
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Yiyiren (Semen Coicis) can not only invigorate spleen to elimi-nate dampness, but also dredge channel blockades by calming endogenous wind. Yiyiren (Semen Coicis) polysaccharide can significantly improve the percentage and phagocytosis index of peritoneal macrophages in mice with insufficient immunity, promote hemolysin and plague forming cell, and help lymphocyte transformation. It can also down-regulate the expression level of Cox-2 gene. Small doses of Yiyiren (Semen Coicis) oil (palmitic acid and palmitate as the key components) showed a respiratory stimulating effect, but large doses showed respiratory depression. It also can expand the pulmonary blood vessels to relieve cough and to improve the pulmonary function. [27] [28] [29] In Chinese medicine, centipede is used to relieve spasms by calming endogenous wind, improving rigidity of muscles, activating collaterals to stop pain, and removing toxicity for eliminating stagnation. Studies show that it can improve microcirculation, prolong coagulation time, and reduce the blood viscosity. It can also lower the serum level of IL-2 and increase the levels of IL-4 and IL-10 in arthritis models, presenting an obvious anti-inflammatory analgesic effect. In clinical observation, centipede showed a strong effect in eliminating phlegm and relieving cough, especially in chronic cough. 30, 31 Leigongteng (Radix et Rhizoma Tripterygii) can dispel pathogenic wind and eliminate phlegm, promote blood circulation for removing obstruction in collaterals, and relieve swelling and pain. Studies confirm that triptolide, one of the main active components in Leigongteng (Radix et Rhizoma Tripterygii), can relieve pulmonary alveolitis and inhibit fibrosis in a mouse model of pulmonary fibrosis. Triptolide also showed anti-inflammatory activity in cultured lung cells in vivo in an acute lung injury model. With functions as an inhibitor of asthma airway remodeling, it is a potential drug for the treatment of lower pulmonary disorders. 32, 33 In conclusion, Xinfeng capsule can improve the pulmonary function in AA rats by adjusting the peripheral blood level of regulatory T cells, inhibiting Th1 cell activation, prompting Th1 cell drift to Th2 cells, inhibiting cellular immunity, and balancing the Th1/Th2 cell ratio. This minimizes the potential harm caused by inflammatory cells on lung tissue, and promotes the ventilation functions of lung tissue.
